We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.
- Authors
Sherman, D R; Mdluli, K; Hickey, M J; Barry, C E, 3rd; Stover, C K
- Abstract
The Mycobacterium tuberculosis AhpC is similar to a family of bacterial and eukaryotic antioxidant proteins with alkylhydroperoxidase (Ahp) and thioredoxin-dependent peroxidase (TPx) activities. AhpC expression is associated with resistance to the front-line antitubercular drug isoniazid in the naturally resistant organisms E. coli and M. smegmatis. We identified several isoniazid-resistant M. tuberculosis isolates with ahpC promoter mutations resulting in AhpC overexpression. These strains were more resistant to cumene hydroperoxide than were wild-type strains. However, these strains were unchanged in their sensitivity to isoniazid, refuting a role for AhpC in detoxification of this drug. All the isoniazid-resistant, AhpC-overexpressing strains were also deficient in activity of the mycobacterial catalase-peroxidase KatG. KatG, the only known catalase in M. tuberculosis, is required for activation of isoniazid. We propose that compensatory ahpC promoter mutations are selected from KatG-deficient, isoniazid-resistant M. tuberculosis during infections, to mitigate the added burden imposed by organic peroxides on these strains.
- Publication
BioFactors (Oxford, England), 1999, Vol 10, Issue 2-3, p211
- ISSN
0951-6433
- Publication type
Journal Article
- DOI
10.1002/biof.5520100219